We are so happy to announce that Gabrielle’s Angel Foundation’s Medical Advisory Board approved the funding of 7 new Medical Research Awards, totaling $1,575,000! 

In addition to the 8 early career scientists who received grants of $225,000 each in 2025, Gabrielle’s Angel Foundation’s Medical Advisory Board also awarded ten grants of $15,000 each. The following grantees were selected for these awards: Dr. MinJung Kim  ~ University of Maryland School of Medicine Dr. Nour Shobaki ~ University of Pennsylvania Dr. […]

Researchers at Columbia University, including 2025 Gabrielle’s Angels Grantee Dr. Aaron Viny, have uncovered a key mechanism that helps explain how certain blood cancers develop. Their study found that mutations in a gene called STAG2 can disrupt the normal development of red blood cells by causing important genetic signals to be sent to the wrong […]

Gabrielle’s Angel Foundation grantee Jaebok Choi recently published a paper in Molecules. This study tested a new experimental drug called BI-5756 in laboratory and mouse models of bone marrow transplantation. The researchers found that BI-5756 helps calm harmful immune reactions by increasing the number of “regulatory” immune cells that act as natural brakes on inflammation, […]

Gabrielle’s Angels grantee Dr. Kevin Liou from MSKCC recently published findings from the clinical trial our grant helped support in the Journal of Clinical Oncology. This study tested whether music therapy delivered over telehealth can help reduce anxiety in cancer survivors as well as cognitive behavioral therapy (CBT), which is the standard first-choice treatment for anxiety. […]

Gabrielle’s Angels grantee Dr. Cigall Kadoch at the Dana-Farber Cancer Institute was part of a team of researchers who discovered a new part of an important gene-regulating machine in our cells, called the SWIFT domain on mSWI/SNF complexes, which helps these molecular machines find and activate specific genes. This mechanism is crucial for normal cell […]

Former Gabrielle’s Angel Foundation Grantee Dr. Ross Levine has been named the Chief Scientific Officer of Memorial Sloan Kettering Cancer Center. We first funded Dr. Levine with a Medical Research Award in 2009 and then a Collaborative Grant in 2013 and have been thrilled to watch him continue to achieve success in his career and […]

We are thrilled to share that Dr. Anthony Letai, a 2007 Gabrielle’s Angel Foundation grantee, has been appointed Director of the National Cancer Institute. We supported Dr. Letai early in his career, funding his project focused on detecting blocks in apoptosis in leukemia stem cells. He has since gone on to achieve extraordinary success, serving […]

Omar Abdel-Wahab, MD, Chair of the Molecular Pharmacology Program at Sloan Kettering Institute (SKI); Evnin Family Chair in Molecular Pharmacology and Attending Physician on the Leukemia Service at Memorial Sloan Kettering Cancer Center (MSK), has been elected to the National Academy of Medicine (NAM), one of the most prestigious honors in the fields of health and medicine. […]

We are proud to announce that Gabrielle’s Angel Foundation’s Medical Advisory Board recently approved the funding for 8 new grants of $225,000 each, totaling $1.8 million! We are delighted to welcome these brilliant investigators to our Gabrielle’s Angels family! DR. URVI SHAH, MD MEMORIAL SLOAN KETTERING CANCER CENTER TITLE OF PROPOSAL: A Decentralized Trial of a […]

A recently published article in Newsweek discusses the groundbreaking advancements in genetic sequencing that are transforming cancer treatment. It highlights how technologies like whole genome sequencing (WGS) are enabling doctors to identify genetic mutations in tumors and personalize treatments for patients, including those with rare or difficult-to-treat cancers. One key example is the case of […]

Marco Ruella, MD, Gabrielle’s Angels grantee in 2014 and 2017 (Medical Advisory Board discretionary funding) and 2019 (Medical Research Award), assistant professor, medicine (hematology-oncology), Perelman School of Medicine; scientific director, Lymphoma Program, the Hospital of the University of Pennsylvania, discusses the implications of findings from a retrospective study evaluating access to and outcomes with commercial […]